(MNPR) – FDA
-
Monopar Therapeutics (MNPR) Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patients
-
Monopar Therapeutics (MNPR) Announces Positive Preclinical Therapeutic Isotope Data for its MNPR-101 Radiopharma Program
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to MNPR Stock Lookup